Monitor for potential stock price volatility around the offering close date and watch for how the company allocates the capital raised, particularly in advancing its AlloCAR T product pipeline. The dilution from issuing new shares could pressure the stock price in the short term.
Price Chart
Executive Summary
Allogene Therapeutics announced a public offering of 87.5 million shares at $2.00 per share, raising approximately $175 million in gross proceeds. The company granted underwriters a 30-day option to purchase up to 13.1 million additional shares. The offering is expected to close on April 16, 2026, subject to customary conditions.
Key Facts
- Allogene Therapeutics priced a public offering of 87.5 million shares at $2.00 per share
- Gross proceeds expected to be approximately $175 million before underwriting discounts and commissions
- Company granted underwriters a 30-day option to purchase up to 13.1 million additional shares
- Proceeds will be used for general corporate purposes including clinical trials, R&D, and capital expenditures
- Offering expected to close on April 16, 2026, subject to customary closing conditions
Financial Impact
Approximately $175 million in gross proceeds from the sale of 87.5 million shares at $2.00 per share, with potential for an additional $26.25 million if the underwriters exercise their option to purchase 13.1 million additional shares
Risk Factors
- Dilution of existing shareholders from issuing 87.5 million new shares
- Market conditions could affect the underwriters' decision to exercise their option for additional shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-157140 |
| Document: d283634d8k.htm | 0001193125-26-157140 |
| Document: d283634dex51.htm | 0001193125-26-157140 |
| Document: d283634dex992.htm | 0001193125-26-157140 |
| Document: d283634dex991.htm | 0001193125-26-157140 |
| Document: 0001193125-26-157140-index-headers.html | 0001193125-26-157140 |
| Document: 0001193125-26-157140-index.html | 0001193125-26-157140 |
| Document: 0001193125-26-157140.txt | 0001193125-26-157140 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 144 | $1.25 $1.25 | · 0.00% | ▲ +0.52% | $1.22 (−2.40%) |
Sep 2, 2026 7w ago | 8-K | $1.98 $1.98 | · 0.00% | ▼ −1.05% | $1.22 (−38.38%) |
Aug 21, 2026 9w ago | 144 | $2.03 $2.17 | ▲ +6.90% | ▲ +6.58% | $1.22 (−39.90%) |
Aug 21, 2026 9w ago | EFFECT | $2.09 $2.03 | ▲ +2.87% | ▲ +2.58% | $1.22 (+41.63%) |
Aug 6, 2026 11w ago | Institutional Cluster | $1.97 $2.01 | ▲ +2.03% | ▲ +1.42% | $1.22 (−38.07%) |
Jun 22, 2026 18w ago | 8-K | $2.07 $2.05 | ▲ +0.97% | ▲ +0.92% | $1.22 (+41.06%) |
Jun 22, 2026 18w ago | 424B5 | $2.07 $2.05 | ▲ +0.97% | ▲ +0.92% | $1.22 (+41.06%) |
May 28, 2026 21w ago | DEFA14A | $2.17 $2.15 | ▼ −0.92% | ▼ −1.18% | $1.22 (−43.78%) |
May 28, 2026 21w ago | 8-K | $2.17 $2.15 | ▼ −0.92% | ▼ −1.18% | $1.22 (−43.78%) |
May 28, 2026 21w ago | Press Release | $2.17 $2.15 | ▼ −0.92% | ▼ −1.20% | $1.22 (−43.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers